house dust mite allergen Report issue

Allergen Approved FDA
AACT DrugBank

Active Ingredient History

NOW
  • Now
House dust mites are various species of acariform mites belonging to the family Pyroglyphidae that are found in association with dust in dwellings. They are known for causing allergies.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Drug Pricing (per unit)

United States

$7.1200
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Alternative names

ae-mite, dermatophagoides pteronyssinus | depigoid dermatophagoides pteronyssinus | dermatofagoides farinae allergen | dermatofagoides pteronyssinus allergen | dermatophagoides allergen | dermatophagoides farinae allergen | dermatophagoides pteronyssinus | dermatophagoides pteronyssinus allergen | dermatophagoides pteronyssinus whole | d. pteronyssinus allergens | dust mite allergen | dust mite extract | european house dust mite | european house dust mite extract | helisen | house dust mit allergen | house dust mite allergen | house dust mite allergen extract placebo | house dust mite extract, dermatophagoides pteronyssinus | house dust mites allergen extract | insects (whole body), mite dermatophagoides farinae | insects (whole body), mite dermatophagoides pteronyssinus | insects (whole body), mite dermatophagoides pteronyssinus | mite allergen extract | mite d.p. | mite d.p. (dermatophagoides pteronyssinus) standardized | mitizax | mk-8237 | mm09 mannosylated | pangramin plus d. pteronyssinus | purethal mites | staloral | sublivac fix mite

Organizations (109)

Research & Development (106)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (4)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (14)

Approved Indications (1)


 

Hypersensitivity, Immediate (approved 1924)

Experimental Indications - Clinical Trial Phases 1-4 (13)


 

Allergy and Immunology (Phase 4)

Asthma (Phase 4)

Conjunctivitis (Phase 3)

Dermatitis, Atopic (Phase 4)

Geriatrics (Phase 3)

Healthy Volunteers (Phase 1)

Hypersensitivity (Phase 4)

Immunotherapy (Phase 3)

Respiratory Hypersensitivity (Phase 3)

Rhinitis (Phase 3)

Rhinitis, Allergic (Phase 4)

Rhinitis, Allergic, Perennial (Phase 4)

Rhinitis, Allergic, Seasonal (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 88
  • # of Trial Organizations: 106

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue